Hsiri Therapeutics is a development stage company focused on discovering and developing therapies for infections due to drug resistant bacteria. Hsiri’s research efforts are focused on two major areas – infections due to mycobacteria and infections due to usual bacterial pathogens. The research concepts for all of Hsiri Therapeutics products originated from the research efforts of Professor Marvin Miller at the University of Notre Dame.